Updated May. 2, 2017 at 6:47 a.m.

Premium Lock Durham-based Parion licenses potential dry-eye drug, could earn $535M

Published: 2017-05-01 11:43:00
Updated: 2017-05-02 06:47:20

Eye research Eye research Image 1 of 4 · Next Image…

​Durham-based Parion Sciences has granted exclusive worldwide development and commercialization rights to its potential therapy for dry eye disease to Shire, a global pharmaceutical company....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders